Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Hahn, D. L.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Cost-effectiveness of Prostate Cancer Screening and Treatment

right arrow David L. Hahn

15 November 1993 | Volume 119 Issue 10 | Pages 1054-1055


TO THE EDITOR:

My Swedish brother-in-law, who has lived and worked in the United States for more than two decades, observes that often Americans act first and analyze later. This tendency is manifest in aggressive recommendations for unproven yet demonstrably morbid screening programs such as those for asymptomatic prostate cancer.

Garnick [1] documents that screening for asymptomatic prostate cancer is unproven and that consensus groups in Sweden, France, Canada, and the United States, as well as the International Union Against Cancer, do not recommend it. Nevertheless, he devotes considerable space to a detailed description of unproven screening procedures recommended by the American Cancer Society and concludes that "a greater effort must be made to promote earlier diagnosis of prostate cancer".

It is time that American physicians recognize what physicians in the rest of the developed world already know: Advocates of screening procedures of unproven benefit but known harm would replace the traditional ethical precept of "primum non nocere" (first, do no harm) with its opposite, "primum facere" (first, do something).


Reference
space
up arrowTop
dotReference

1. Garnick MB. Prostate cancer: screening, diagnosis and management. Ann Intern Med. 1993; 118:804-18.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Hahn, D. L.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online